I know i'm a broken record but their is going to be a cap raise coming soon. They might wait for the pop and then goto markets to help fund acquisition and pay down debt.
I'm long but i'm very objective and he could be a one off, but it really is a good point! Its a little squirely on STML's part.
they are running the decision toward the end of the deadline and maybe they are backed up or maybe it is a tough decision meaning a higher probability this gets rebid.
your ignorant and my guess is you own under 5,000 shares, their is a core group on here that have significant positions, mine isn't as significant as the others, but your ignorant posts lead me to believe that you probably have an etrade account and live with mom in an apartment.
I would be interested or excited to see a partner take an equity stake for cash but the problem is there is so few shares out there. They will need cash in the next 12 months. Phase 3 is expensive to conduct unless they get a partner on board.
the fact you put in lolzzzzz in a post says a lot.
do you care to make a prediction so we can lambast you when it doesn't come out?
waiting? price and date?
Welcome to the stock market. That is what Biotechs do and not to mention other public start ups. Let me also rephrase, have you read the trial results, based on early trial results, the two drugs look stronger than most based on complete responses and overall responses. Why do large pharma companies buyout smaller ones with no approved drugs or partner and pay for trials??
Learn about market caps and come back!!
Unless i'm reading this wrong:
On a final note, as we increase our involvement with multinational customers, and their service requirements, we are receiving new conformations of the validity of our enterprise level MMS strategy. This strategy will require management to acquire some built on product capabilities, optimize its services delivery and identify an international reach and support capability.
Do you understand the drugs they have in the pipeline and the phase 2 data that has come out?
Do you realize their market cap is only 280 million? The drugs they are working on are billion dollar drugs. $250 market cap is very reasonable and they have 90 million in cash.
I tend to agree, but playing Devil's advocate, here is what I worry and took away from transcript, haven't had a chance to listen, just read.
Their commercial contracts tend to be small versus large government. Did anyone notice that they stated they would have to make acquisitions? I think if or when the stock pops, they are going to raise funds, I know I said it before, but I"m sticking with it.
It sounds like more positive things are happeniing compared to the past but numbers are stronger than talk. They really rely on government for growth and profits.